Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

MJS.V, CRWE, VITA, LXRX, ARYX- Stock Reports! from Stock-PR.com

Stock-PR Reporting

stockpr_logo-site

 

FREE Daily Stock Alerts From Stock-PR.com

chartstockalert

________________________________________

http://pennyomega.com/img/mjs.jpg Majestic Gold Corp. (TSX.V:MJS)

Majestic Gold Corp. (TSX-V:MJS) recently announced the results of an updated resource estimate on its Song Jiagou Mine.

As part of the ongoing assessment on the Song Jiagou Mine, Wardrop Engineering Inc. has revised their previous resource estimate (NR 23 April, 2010) as a result of the revision to the contract mining costs (NR 30 September 2010) which allowed cut-off grades to be reduced from 0.40 g/t to 0.30 g/t and warranted a revision of the block model.

Subsequent to the initial resource estimate, Wardrop determined that rotating the block model perpendicular to drilling direction was the most favorable orientation to evaluate the deposit and to calculate the revised resource. The new cut-off grade and the re-orientation of the model significantly increased the overall size of the resource and the contained ounces of gold in both the inferred and indicated categories.

China has a long history of gold production. As early as 1091 BC, gold was legalized as money (as an alternative to silk), circulating in little squares. Hebei province, one of the main mining areas, claims production for over three thousand years. The Zhao Yuan mine in Shandong province has been worked for over a thousand years; other Shandong mines date from the 17th century.

After more than a century on the throne, South Africa has been deposed as the world's biggest producer of gold, with its estimated 2007 output, of 272 tonnes, falling just short of the 276 tonnes of the yellow metal produced by the new number one, China. While Chinese gold production increased by an estimated 12% year-on-year, South African mines produced 8% less gold than in 2006, according to precious metals consultancy GFMS's 'Gold Survey 2007 - Update 2'.

Compared to other countries, China's resource sector is relatively underdeveloped. A historical lack of investment capital and new technologies has prevented many of its quality properties from being fully explored or developed. China is now establishing an open policy to encourage foreign investment in gold exploration and mining. In March 2003, the National Development and Reform Commission (NDRC) was formed and soon established new regulations for exploration and mining licenses similar to those of Australia and North America.

By December 2003, the Chinese State Council published "China's Policy on Mineral Resources". The overall objectives of the policy are to: depend on and encourage the exploitation and exploration of China's own mineral resources; increase China's domestic capability of mineral resource supply; import foreign capital and technology; and, to help Chinese mining enterprises and mineral products enter the international market. In mid 2003 the Shanghai Gold Exchange was also established, operating as a free-market forum for gold trading and pricing.

http://doubleinstocks.com/img/crwe_logo3_170x120.gif

Crown Equity Holdings Inc. (OTCBB:CRWE) is pleased to report its financial results for the nine month period ending September 30, 2010. Revenue for the nine months totaled $1,073,383 compared to $418,959 during 2009. Crown Equity Holdings Inc. incurred an operating loss of $54,527 for the nine months ending September 30, 2010 compared to an operating loss of $36,923 during the same period in 2009. Net loss of $343,049 for the nine months ending September 30, 2010 compared to a net loss of $29,379 for the same period in 2009. The net loss in 2010 was attributed mostly to an unrealized loss of $307,544 on securities held by Crown Equity Holdings Inc.

Crown Equity Holdings Inc. is extending its internet footprint internationally to include the following countries; Argentina, Brazil, Canada, China, France, Germany, Hong Kong, India, Indonesia, Italy, Japan, Korea, Malaysia, Mexico, New Zealand, Pakistan, Russia, Singapore, Spain, South Africa, Taiwan, United Arab Emirates and United Kingdom.

Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused its primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients. Crown Equity Holdings Inc. announced in June of this year its 1- 10 forward stock split.

Orthovita Inc. (Nasdaq:VITA) announced that it will present at the J.P. Morgan 29th Annual Healthcare Conference in San Francisco. Antony Koblish, President and Chief Executive Officer of Orthovita, is scheduled to present on Thursday, January 13, 2011, at 7:30 a.m. Pacific Time, at the Westin St. Francis Hotel, 335 Powell Street, San Francisco, CA 94102. A live audio webcast of the presentation will be available, and can be accessed for 90 days following the conference, by visiting http://jpmorgan.metameetings.com/webcasts/healthcare11/directlink?ticker=vita.
Orthovita, Inc., a specialty spine and orthopedic company, develops and markets orthobiologic and biosurgery products. The company’s orthobiologics platform offers products for the fusion, regeneration, and fixation of human bone; and the biosurgery platform provides products for controlling intra-operative bleeding/hemostasis.

Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX) announced top-line results from a recently completed Phase 2a study of LX2931 in patients with rheumatoid arthritis (NYSE:RA). LX2931 is an orally-delivered, small molecule drug candidate that inhibits sphingosine-1-phosphate (S1P) lyase, an enzyme important for modulating the immune system by controlling S1P levels in lymphoid tissues. The trial was the first test of this new anti-inflammatory mechanism of action in patients and was designed to obtain safety and tolerability information and signals of efficacy.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of human disease, including immunology, metabolism, cardiology, and ophthalmology.

ARYx Therapeutics, Inc. (Nasdaq:ARYX) provided further clarification of its status as an operating company, including the on-going appointment of its officers on behalf of the Company. The NASDAQ Staff has requested additional clarification about the Company’s operations in conjunction with their on-going consideration of the Company’s eligibility for continued listing on The NASDAQ Capital Market. ARYx remains operational, with specific activities underway, which are designed to further the development and approval of naronapride, and to enhance the value of the Company’s assets. In addition, four officers of ARYx remain in their respective roles as officers, appointed by the board of directors to operate the company in good standing.
ARYx Therapeutics, Inc., a biopharmaceutical company, focuses on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with commercialized drugs in the United States. The company uses its RetroMetabolic Drug Design technology to design structurally unique molecules that retain the efficacy of original drugs.

**************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Stock-PR.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold Stock-PR.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://stock-pr.com/disclaimer).Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received twenty-five thousand dollars in cash from a third party for (thirty) days of advertising for Majestic Gold Corp, TSX Venture Exchange (TSX.V:MJS) and the Frankfurt Stock Exchange (FSE:MJT).

Sign Up For Free Stock Alerts At http://stock-pr.com/signup

http://stock-pr.com/img/stock-pr_buscard.jpg

________________________________________

Be Sure To Visit stock-pr.ning.com

**********************************************************************

The views expressed in any article, reports, writings are not necessarily the views of Crown Equity Holdings Inc. its officers, directors, staff, contractors or employees. They do not represent the views or opinions of this site. Views expressed in articles are those of the author alone.